PMID- 25399488 OWN - NLM STAT- MEDLINE DCOM- 20160201 LR - 20220321 IS - 1440-1843 (Electronic) IS - 1323-7799 (Linking) VI - 20 IP - 2 DP - 2015 Feb TI - Repeated inhalation of sevoflurane inhibits airway inflammation in an OVA-induced mouse model of allergic airway inflammation. PG - 258-63 LID - 10.1111/resp.12439 [doi] AB - BACKGROUND AND OBJECTIVE: Repeated inhalation of sevoflurane (SVF) can benefit asthmatic patients by bronchodilation. However, the impact of repeated inhalation of SVF on allergic airway inflammation has not been clarified. This study was aimed at investigating the effects of repeated inhalation of SVF on airway inflammation in mice. METHODS: Female C57BL/6 mice were sensitized with ovalbumin (OVA) and treated by inhalation with SVF or vehicle daily for seven consecutive days, immediately followed by OVA challenge. Airway inflammation was evaluated by counting the numbers of different types of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF), histology, cytokine measurements and mucus production in individual mice. RESULTS: In comparison with the OVA group, repeated inhalation of SVF significantly reduced the numbers of total cells, eosinophils, lymphocytes, macrophages and neutrophils (P < 0.05 to P < 0.01), and the levels of BALF tumour necrosis factor-alpha and lung high-mobility group box 1 (P < 0.01), accompanied by elevated levels of BALF interleukin-10 in allergic mice (P < 0.05). Repeat inhalation of SVF decreased the levels of serum OVA-specific immunoglobulin E (IgE) and mitigated allergic airway epithelial goblet cell hyperplasia and mucus hypersecretion in allergic mice (P < 0.01). CONCLUSIONS: Repeated inhalation of SVF inhibits allergic airway inflammation by reducing inflammatory infiltrates, improving the imbalance of cytokine responses and mitigating allergen-specific IgE responses and goblet cell hyperplasia in mice. CI - (c) 2014 Asian Pacific Society of Respirology. FAU - Shen, Qi-Ying AU - Shen QY AD - Department of Pulmonary, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. FAU - Fang, Lei AU - Fang L FAU - Wu, Hui-Mei AU - Wu HM FAU - He, Fang AU - He F FAU - Ding, Pei-Shan AU - Ding PS FAU - Liu, Rong-Yu AU - Liu RY LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20141117 PL - Australia TA - Respirology JT - Respirology (Carlton, Vic.) JID - 9616368 RN - 0 (Bronchodilator Agents) RN - 0 (HMGB1 Protein) RN - 0 (Methyl Ethers) RN - 0 (TNF protein, human) RN - 0 (Tumor Necrosis Factor-alpha) RN - 130068-27-8 (Interleukin-10) RN - 37341-29-0 (Immunoglobulin E) RN - 38LVP0K73A (Sevoflurane) RN - 9006-59-1 (Ovalbumin) SB - IM MH - Animals MH - Asthma/blood/chemically induced/*drug therapy MH - Bronchoalveolar Lavage Fluid/chemistry/cytology MH - Bronchodilator Agents/*administration & dosage MH - Disease Models, Animal MH - Eosinophils MH - Female MH - Goblet Cells/*pathology MH - HMGB1 Protein/analysis MH - Hyperplasia/pathology MH - Immunoglobulin E/blood MH - Inflammation/chemically induced/drug therapy MH - Interleukin-10/analysis MH - Lung/*pathology MH - Lymphocyte Count MH - Macrophages MH - Methyl Ethers/*administration & dosage MH - Mice MH - Mice, Inbred C57BL MH - Mucus/drug effects/metabolism MH - Neutrophils MH - Ovalbumin MH - Sevoflurane MH - Tumor Necrosis Factor-alpha/analysis OTO - NOTNLM OT - allergen OT - high-mobility group box 1 OT - inflammation OT - inhalational anaesthetic OT - sevoflurane EDAT- 2014/11/18 06:00 MHDA- 2016/02/02 06:00 CRDT- 2014/11/18 06:00 PHST- 2014/06/16 00:00 [received] PHST- 2014/08/31 00:00 [revised] PHST- 2014/09/08 00:00 [revised] PHST- 2014/09/15 00:00 [accepted] PHST- 2014/11/18 06:00 [entrez] PHST- 2014/11/18 06:00 [pubmed] PHST- 2016/02/02 06:00 [medline] AID - 10.1111/resp.12439 [doi] PST - ppublish SO - Respirology. 2015 Feb;20(2):258-63. doi: 10.1111/resp.12439. Epub 2014 Nov 17.